LGND Ligand Pharmaceuticals
Ligand Pharmaceuticals earnings company data as of 4:48 AM ET 10/4
Scheduled
1 period · newest first · EPS & Rev stacked · nothing reported yet
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 1.44 | — | — |
| Rev | — | — | — |
SEC filings
Recent issuer filings from EDGAR · 17 shown · open Filing / Doc on SEC.gov
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01,8.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K/A | 9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.01,2.01,2.03,7.01,9.01 | Filing Doc | |
| 8-K | 1.01,2.03,3.02,8.01,9.01 | Filing Doc | |
| 8-K | 1.01,8.01,9.01 | Filing Doc | |
| 8-K | 5.02,5.07 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.02 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K | 1.01,8.01 | Filing Doc | |
| DEFA14A | Filing Doc |
No filings match this filter.
Consensus estimates · SEC filings remain the official record · not investment advice